Clinical Trials in Seattle

Showing 5281-5300 of 7,135 trials

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

NCT00363012

RATIONALE: Studying the immune response to a vaccine made from HER2/neu protein may help doctors plan better treatment for patients with breast cancer that overexpresses HER2. PURPOSE: This clinical trial is studying the immune response in patients who have undergone vaccine therapy for stage III or stage IV breast cancer that overexpresses HER2.

Breast Cancer

University of Washington56 participantsStarted Apr 2006

Seattle, Washington, United States • Seattle, Washington, United States

TERMINATEDPhase 2< 1 mile

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

NCT01465386

This phase II trial studies how well bortezomib works in treating patients with high-risk acute myeloid leukemia (AML) in remission. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more

Fred Hutchinson Cancer Center6 participantsStarted Nov 2011

Seattle, Washington, United States

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Find Trials by Condition in Seattle

Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS

High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Short Term Pancreatic Stenting Registry

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Study In People With Type 2 Diabetes

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Caffeine as a Therapy for Parkinson's Disease

Natalizumab Re-Initiation of Dosing

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Clinical Trial of Peripheral Prism Glasses for Hemianopia